Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
2026 · third_quarter · Q3
Regulatory affairs
Filing targets: Health & Human Services, Dept of (HHS)
NEWLIGHT HEALTHCARE via MS. LAURA LAWLOR
2026 · third_quarter · Q3
Source: Senate LDA
Regulatory affairs
Filing targets: Health & Human Services, Dept of (HHS)
MEDIFY AIR via MS. LAURA LAWLOR
2026 · first_quarter · 1T
Regulatory affairs
Filing targets: Health & Human Services, Dept of (HHS)
NEWLIGHT HEALTHCARE via MS. LAURA LAWLOR
2026 · second_quarter · Q2
Regulatory affairs
Filing targets: Health & Human Services, Dept of (HHS)
2026 · second_quarter · Q2
Regulatory affairs
Filing targets: Health & Human Services, Dept of (HHS)
2026 · first_quarter · Q1
Regulatory affairs
Filing targets: Health & Human Services, Dept of (HHS)
MEDIFY AIR via MS. LAURA LAWLOR
2026 · first_quarter · Q1
Regulatory affairs
Filing targets: Health & Human Services, Dept of (HHS)
NEWLIGHT HEALTHCARE via MS. LAURA LAWLOR
2026 · first_quarter · Q1
Regulatory affairs
Filing targets: Health & Human Services, Dept of (HHS)
2025 · fourth_quarter · Q4
Regulatory affairs
Filing targets: Health & Human Services, Dept of (HHS)
MEDIFY AIR via MS. LAURA LAWLOR
2025 · fourth_quarter · Q4
Regulatory affairs
Filing targets: Health & Human Services, Dept of (HHS)
NEWLIGHT HEALTHCARE via MS. LAURA LAWLOR
2025 · fourth_quarter · Q4
Regulatory affairs
Filing targets: Health & Human Services, Dept of (HHS)
2025 · third_quarter · 3A
Regulatory affairs
Filing targets: Health & Human Services, Dept of (HHS)
MEDIFY AIR via MS. LAURA LAWLOR
2025 · third_quarter · Q3
Regulatory affairs
Filing targets: Health & Human Services, Dept of (HHS)
NEWLIGHT HEALTHCARE via MS. LAURA LAWLOR
2025 · third_quarter · Q3
Regulatory affairs
Filing targets: Health & Human Services, Dept of (HHS)
2025 · third_quarter · RR
Regulatory affairs
MEDIFY AIR via MS. LAURA LAWLOR
2025 · second_quarter · Q2
Regulatory affairs
Filing targets: Health & Human Services, Dept of (HHS)
NEWLIGHT HEALTHCARE via MS. LAURA LAWLOR
2025 · second_quarter · Q2
Regulatory affairs
Filing targets: Health & Human Services, Dept of (HHS)
NEWLIGHT HEALTHCARE via MS. LAURA LAWLOR
2025 · first_quarter · Q1
Regulatory affairs
Filing targets: Health & Human Services, Dept of (HHS)
MEDIFY AIR via MS. LAURA LAWLOR
2025 · first_quarter · Q1
Regulatory affairs
Filing targets: Health & Human Services, Dept of (HHS)
MEDIFY AIR via MS. LAURA LAWLOR
2025 · first_quarter · RR
Regulatory affairs
NEWLIGHT HEALTHCARE via MS. LAURA LAWLOR
2024 · fourth_quarter · Q4
Regulatory affairs
Filing targets: Health & Human Services, Dept of (HHS)
NEWLIGHT HEALTHCARE via MS. LAURA LAWLOR
2024 · third_quarter · Q3
Regulatory affairs
NEWLIGHT HEALTHCARE via MS. LAURA LAWLOR
2024 · second_quarter · Q2
Regulatory affairs
NEWLIGHT HEALTHCARE via MS. LAURA LAWLOR
2024 · first_quarter · Q1
Regulatory affairs
NEWLIGHT HEALTHCARE via MS. LAURA LAWLOR
2023 · fourth_quarter · Q4
Regulatory affairs
NEWLIGHT HEALTHCARE via MS. LAURA LAWLOR
2023 · third_quarter · Q3
Regulatory affairs
NEWLIGHT HEALTHCARE via MS. LAURA LAWLOR
2023 · second_quarter · Q2
Regulatory affairs
NEWLIGHT HEALTHCARE via MS. LAURA LAWLOR
2023 · first_quarter · Q1
Regulatory affairs
NEWLIGHT HEALTHCARE via MS. LAURA LAWLOR
2022 · fourth_quarter · Q4
Regulatory affairs
NEWLIGHT HEALTHCARE via MS. LAURA LAWLOR
2022 · third_quarter · Q3
Regulatory affairs
NEWLIGHT HEALTHCARE via MS. LAURA LAWLOR
2022 · third_quarter · RA
Hospital policy
NEWLIGHT HEALTHCARE via MS. LAURA LAWLOR
2021 · second_quarter · 2T
Managed healthcare
Filing targets: Health & Human Services, Dept of (HHS)
NEWLIGHT HEALTHCARE via MS. LAURA LAWLOR
2021 · first_quarter · Q1
Managed healthcare
Filing targets: Health & Human Services, Dept of (HHS)
NEWLIGHT HEALTHCARE via MS. LAURA LAWLOR
2020 · fourth_quarter · Q4
Healthcare financing
Filing targets: Health & Human Services, Dept of (HHS)
NEWLIGHT HEALTHCARE via MS. LAURA LAWLOR
2020 · third_quarter · Q3
Healthcare financing
Filing targets: Health & Human Services, Dept of (HHS)
NEWLIGHT HEALTHCARE via MS. LAURA LAWLOR
2020 · second_quarter · Q2
Healthcare financing
Filing targets: Health & Human Services, Dept of (HHS)
NEWLIGHT HEALTHCARE via MS. LAURA LAWLOR
2020 · first_quarter · 1A
Health care financing
Filing targets: Health & Human Services, Dept of (HHS)
NEWLIGHT HEALTHCARE via MS. LAURA LAWLOR
2020 · first_quarter · RR
Healthcare for aging Americans; nursing home issues
NOVO NORDISK INC via MS. LAURA LAWLOR
2016 · fourth_quarter · 4T
care and treatment of diabetes
Filing targets: Health & Human Services, Dept of (HHS)
NOVO NORDISK INC via MS. LAURA LAWLOR
2016 · third_quarter · Q3
care and treatment of diabetes
Filing targets: Health & Human Services, Dept of (HHS)
NOVO NORDISK INC via MS. LAURA LAWLOR
2016 · second_quarter · Q2
care and treatment of diabetes
Filing targets: Health & Human Services, Dept of (HHS)
NOVO NORDISK INC via MS. LAURA LAWLOR
2016 · first_quarter · Q1
care and treatment of diabetes
Filing targets: Health & Human Services, Dept of (HHS)
NOVO NORDISK INC via MS. LAURA LAWLOR
2016 · first_quarter · Q1
The care and treatment of diabetes.
Filing targets: Health & Human Services, Dept of (HHS)
NOVO NORDISK INC via MS. LAURA LAWLOR
2015 · fourth_quarter · Q4
The care and treatment of diabetes.
Filing targets: Health & Human Services, Dept of (HHS)
NOVO NORDISK INC via MS. LAURA LAWLOR
2015 · fourth_quarter · Q4
The care and treatment of diabetes.
Filing targets: Health & Human Services, Dept of (HHS)
NOVO NORDISK INC via MS. LAURA LAWLOR
2015 · third_quarter · Q3
The care and treatment of diabetes.
Filing targets: Health & Human Services, Dept of (HHS)
NOVO NORDISK INC via MS. LAURA LAWLOR
2015 · second_quarter · Q2
The care and treatment of diabetes.
Filing targets: Health & Human Services, Dept of (HHS)
NOVO NORDISK INC via MS. LAURA LAWLOR
2015 · first_quarter · Q1
The care and treatment of diabetes.
Filing targets: Health & Human Services, Dept of (HHS)
NOVO NORDISK INC via MS. LAURA LAWLOR
2014 · fourth_quarter · Q4
care and treatment of diabetes
Filing targets: Health & Human Services, Dept of (HHS)
NOVO NORDISK INC via MS. LAURA LAWLOR
2014 · third_quarter · Q3
care and treatment of diabetes
Filing targets: Health & Human Services, Dept of (HHS)
NOVO NORDISK INC via MS. LAURA LAWLOR
2014 · second_quarter · Q2
care and treatment of diabetes
Filing targets: Health & Human Services, Dept of (HHS)
NOVO NORDISK INC via MS. LAURA LAWLOR
2014 · first_quarter · Q1
care and treatment of diabetes
Filing targets: Health & Human Services, Dept of (HHS)
NOVO NORDISK INC via MS. LAURA LAWLOR
2013 · fourth_quarter · Q4
care and treatment of diabetes
Filing targets: Health & Human Services, Dept of (HHS)
NOVO NORDISK INC via MS. LAURA LAWLOR
2013 · third_quarter · Q3
care and treatment of diabetes
Filing targets: Health & Human Services, Dept of (HHS)
NOVO NORDISK INC via MS. LAURA LAWLOR
2013 · second_quarter · Q2
Care and treatment of diabetes
Filing targets: Health & Human Services, Dept of (HHS)
NOVO NORDISK INC via MS. LAURA LAWLOR
2012 · first_quarter · Q1
Diabetes care and treatment
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVO NORDISK INC via MS. LAURA LAWLOR
2011 · fourth_quarter · Q4
Diabetes care and treatment
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVO NORDISK INC via MS. LAURA LAWLOR
2011 · third_quarter · Q3
Diabetes care and treatment
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVO NORDISK INC via MS. LAURA LAWLOR
2011 · second_quarter · Q2
Diabetes care and treatment
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVO NORDISK INC via MS. LAURA LAWLOR
2011 · first_quarter · Q1
Diabetes care and treatment
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVO NORDISK INC via MS. LAURA LAWLOR
2010 · fourth_quarter · Q4
Diabetes care and treatment
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVO NORDISK INC via MS. LAURA LAWLOR
2010 · third_quarter · Q3
Diabetes care and treatment
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVO NORDISK INC via MS. LAURA LAWLOR
2010 · second_quarter · Q2
Diabetes care and treatment
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVO NORDISK INC via MS. LAURA LAWLOR
2010 · first_quarter · Q1
Diabetes care and treatment
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVO NORDISK INC via MS. LAURA LAWLOR
2009 · fourth_quarter · Q4
Diabetes care and treatment
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVO NORDISK INC via MS. LAURA LAWLOR
2009 · third_quarter · Q3
Diabetes care and treatment
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVO NORDISK INC via MS. LAURA LAWLOR
2009 · second_quarter · Q2
Diabetes care and treatment
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VIAGEN INC via MS. LAURA LAWLOR
2009 · second_quarter · 2T
FDA regulations, guidance, rules
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VIAGEN INC via MS. LAURA LAWLOR
2009 · first_quarter · Q1
FDA regulations, guidance, rules
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVO NORDISK INC via MS. LAURA LAWLOR
2009 · first_quarter · Q1
Diabetes care and treatment
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VIAGEN INC via MS. LAURA LAWLOR
2008 · fourth_quarter · 4A
FDA regulations, guidance, rules
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VIAGEN INC via MS. LAURA LAWLOR
2008 · fourth_quarter · Q4
FDA regulations, guidance, rules
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVO NORDISK INC via MS. LAURA LAWLOR
2008 · fourth_quarter · Q4
Diabetes Care and Treatment
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVO NORDISK INC via MS. LAURA LAWLOR
2008 · third_quarter · Q3
Diabetes care and treatment
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VIAGEN INC via MS. LAURA LAWLOR
2008 · third_quarter · Q3
FDA regulations, guidance, rules
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVO NORDISK INC via MS. LAURA LAWLOR
2008 · second_quarter · Q2
Diabetes care and treatment
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VIAGEN INC via MS. LAURA LAWLOR
2008 · second_quarter · Q2
FDA regulations/guidance/rules
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVO NORDISK INC via MS. LAURA LAWLOR
2008 · first_quarter · Q1
Diabetes care and treatment
VIAGEN INC via MS. LAURA LAWLOR
2008 · first_quarter · Q1
FDA regulations/guidance/rules
NOVO NORDISK INC via MS. LAURA LAWLOR
2008 · first_quarter · Q1
Diabetes care and treatment
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVO NORDISK INC via MS. LAURA LAWLOR
2007 · year_end · YY
Diabetes care and treatment
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, UNDETERMINED
NOVO NORDISK INC via MS. LAURA LAWLOR
2007 · year_end · RR
Diabetes care and treatment
Diabetes care and treatment
VIAGEN INC via MS. LAURA LAWLOR
2007 · year_end · YY
FDA regulatory/guidance rules
Filing targets: Health & Human Services, Dept of (HHS)
NOVO NORDISK INC via MS. LAURA LAWLOR
2007 · mid_year · RR
Diabetes care and treatment
Diabetes care and treatment
VIAGEN INC via MS. LAURA LAWLOR
2007 · mid_year · RR
Agricultural biotech
Agricultural biotech
Agricultural biotech